Skip to content
Open access

Membrane Lipids and Water Shape the Unbinding Kinetics of ZM241385 from Human Adenosine A2A Receptor Variants

Sep 2026 · bioRxiv · 0 citations · 9 references
Biology

TL;DR

This work uncovers a solvent-mediated mechanism of ligand dissociation from an important pharmaceutical target, the adenosine receptor A2A, and identifies receptor–lipid interactions along the dissociation pathway as a potential target for rationally tuning drug kinetics.

Abstract

Ligand residence time is increasingly recognized as an important determinant of drug efficacy. In the human adenosine A2A receptor (hA2AR) bound to the high-affinity antagonist ZMA, mutations at the extracellular entrance of the binding pocket markedly accelerate ZMA dissociation while largely preserving binding affinity. This effect has been attributed to disruption of the E169ECL2-H7.29 salt bridge that constrains the extracellular entrance in the wild-type receptor. However, how the interaction network is reorganized after salt-bridge disruption remains unknown. Here, we combine well-tempered metadynamics and infrequent metadynamics simulations to characterize the ZMA dissociation pathway and transition-state ensemble. The simulations reproduce the experimentally observed trend in dissociation rates and reveal that the hydrogen-bond network stabilizing ZMA in the bound state is largely replaced by water-mediated interactions during unbinding. In the mutants, disruption of the E169ECL2–H7.29 interaction expands the binding pocket and increases hydration, while additional ligand–lipid interactions emerge specifically at the transition state. These interactions are substantially less frequent in the wild type, indicating that membrane lipids can directly participate in ligand escape when the extracellular gate is disrupted. Thus, the mutations selectively reshape the transition-state interaction network – including recruitment of membrane lipids. Thus, the interaction of the latter with the ligand accompanies and may contribute to the mutants’ reduced dissociation barrier, thereby facilitating ligand release. Significance Drug efficacy depends not only on how tightly a ligand binds its target, but also on how long it remains bound. Why mutations can dramatically alter residence time without substantially changing binding affinity remains poorly understood. Here, we uncover a solvent-mediated mechanism of ligand dissociation from an important pharmaceutical target, the adenosine receptor A2A. For this system, the bound-state hydrogen-bond network is replaced by water-mediated interactions during unbinding, while lipid interactions emerge specifically in the receptor variants. These findings identify receptor–lipid interactions along the dissociation pathway as a potential target for rationally tuning drug kinetics.

Read PDF

Similar papers

Open access Aug 2026

Thermodynamic, Kinetic, and Structural Determinants of Ligand Selectivity in A2A and A2B Adenosine Receptors

G protein-coupled receptors are major pharmacological targets, yet achieving subtype selectivity remains challenging when closely related receptors share highly conserved orthosteric binding sites. Here, we investigate the molecular determinants governing ligand recognition and unbinding at the adenosine A2A and A2B re...

Omar Alsina, S. Di Cristofano, S. Raniolo et al. · 0 citations
Open access Sep 2026

Atomistic Insights into TRPC6–Caveolin-1 Interactions Interface via All-Atom Molecular Dynamics Simulations: Structural and Energetic Basis for Selective Modulation

The molecular determinants governing TRPC6 stabilization and its interaction with caveolin-1 (CAV1) remain poorly defined, despite their critical role in caveolae organization and signaling. The absence of atomistic structural models has hindered a mechanistic understanding of how TRPC6 is recruited to, and stabilized...

Shayesteh Bazsefidpar, Alejandro Rodriguez, Masayuki X. Mori et al. · 0 citations
Open access Aug 2026

Agonist Binding Reshapes the Kinetic Landscape and Allosteric Communication of APLNR Toward Activation-Competent States

APLNR is a therapeutically important G protein-coupled receptor (GPCR) implicated in cardiovascular and metabolic regulation; however, how agonist binding reorganizes receptor dynamics to promote signaling competence remains poorly understood. Here, we used the small-molecule agonist CMF-019 as a representative ligand...

Hong-Xun Dai, Jun-Yao Zhu, Bao Zhang et al. · 0 citations
Open access Sep 2026

Structural determinants of Mac1 inhibition: Lessons from ligand binding patterns.

This study comprehensively analyzes how various inhibitors bind to the SARS-CoV-2 macrodomain Mac1, a key protein implicated in hampering the host's immune response following viral infection. In this study we used volume-based metadynamics simulations to investigate the binding mechanisms of ADP-ribose and two Mac1 inh...

Verena Weber, Sarah Knapp, Patricia Korn et al. · 0 citations
Sep 2026

Functional group-dependent stabilization and dissociation mechanisms of EGFR allosteric inhibitors.

Allosteric inhibitors targeting the αC-helix-adjacent pocket provide an alternative strategy to overcome resistance associated with ATP-site mutations. However, the structural and thermodynamic determinants governing their stability across resistant EGFR variants remain incompletely understood. Here, we comparatively i...

Amina Tariq, M. Shoaib, Ling-Bo Qu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.